Januvia is an oral anti-diabetic medicine which helps in keeping blood sugar levels under control. This is achieved by stimulating pancreas to secrete more insulin and less glucagon (hormone responsible for elevating blood sugar levels).
Januvia is composed of Sitagliptin, which is an oral hypoglycemic agent. It acts on the beta cells of pancreas and stimulates release of insulin. Sitagliptin also acts on alpha cells of pancreas and blocks the release of glucagon.
Along with Sitagliptin, other inactive ingredients also form part of Januvia. These inactive ingredients help Sitagliptin to act.
Januvia is an oral anti-diabetic and used for treatment of type 2 diabetes. It can be taken for treatment of gestational diabetes by pregnant ladies, after consulting with a gynecologist. Pre-diabetes is a condition where blood sugar levels are high on more than one occasion and patient has some pre-disposing factors for development of diabetes.
Januvia will tend to display side effects in hypersensitive patients, or if it is not taken correctly. Some of the side effects of Januvia are as follows:
If patients feel a progressive increase in these symptoms, they should inform their doctor immediately and stop the medicine for time being.
Patients who use Januvia are given certain instructions to follow in order to avoid development of harmful drug reactions. Some of these instructions are given below:
Adhering to these instructions helps to avoid unfavorable drug reactions and preventing health complications.
Other drugs comprising of Sitagliptin can be used as suitable alternatives for Januvia. One such drug has been listed below:
Istavel should not be used in place of Januvia unless advised by a diabetologist.